top of page

Profile
Join date: Sep 9, 2024
Posts (211)
Apr 8, 2026 ∙ 1 min
Embecta to Acquire Owen Mumford in $300M Deal to Expand Drug-Delivery Portfolio
Parsippany, NJ, March 24, 2026 (Yahoo Finance) -- Embecta has agreed to acquire Owen Mumford to strengthen its drug-delivery business. The transaction, valued at approximately $300 million, will add a range of injection and medical device products to Embecta’s portfolio. The deal is expected to enhance the company’s capabilities in supporting patients with chronic conditions. Read full article here .
118
0
Apr 8, 2026 ∙ 1 min
ImpediMed Appoints Erik Anderson as CEO
Brisbane, CA, April 7, 2026 (ImpediMed) — ImpediMed has named Erik Anderson as its new chief executive officer. The leadership change is intended to guide the company’s strategic direction and support expansion of its medical technology portfolio. The appointment comes as ImpediMed focuses on advancing its commercial operations and growth initiatives. Read full article here .
116
0
Apr 8, 2026 ∙ 1 min
Neurocrine Biosciences Details $2.9B Deal to Strengthen Pipeline
San Diego, CA, April 7, 2026 (Yahoo Finance) -- Neurocrine Biosciences has outlined a transaction valued at approximately $2.9 billion aimed at expanding its therapeutic portfolio. The deal is designed to enhance the company’s pipeline with additional clinical-stage assets. The move supports Neurocrine’s strategy to drive long-term growth through targeted business development initiatives. Read full article here .
110
0
bancheta6
Editor
Admin
More actions
bottom of page